Literature DB >> 12135039

Detection of HCV RNA in gastric mucosa-associated lymphoid tissue by in situ hybridization: evidence of a new extrahepatic localization of HCV with increased risk of gastric malt lymphoma.

Antonio Tursi1, Giovanni Brandimante, Francesco Chiarelli, Anna Spagnoli, Monica Torello.   

Abstract

OBJECTIVES: Mucosa-associated lymphoid tissue (MALT) is absent in the normal gastric mucosa but it can develop in several conditions, such as Helicobacter pylori infection. A certain correlation between hepatitis C virus (HCV) infection and low grade MALT lymphomas has recently been reported. The aim of this study was to investigate the presence of HCV RNA in acquired gastric MALT of HCV-infected patients using the in situ hybridization technique.
METHODS: Twenty-five patients (16 male and nine female, average age = 56.6 yr [range = 33-75]) affected by chronic HCV hepatitis and with gastric MALT were studied. Giemsa stain and the rapid urease test were also used to evaluate the presence of H. pylori. A polymerase chain reaction product corresponding to the complete 5' noncoding region of the HCV genome was cloned directly in the pCR 1000 vector on gastric biopsies with acquired MALT.
RESULTS: Twenty patients showed grade 2 gastric MALT and five showed grade 3, and H. pylori's presence was detected in 18 of 25 patients (72%). Using in situ hybridization, we detected HCV RNA in gastric acquired MALT of seven of 25 patients (28%): five showed grade 2 gastric MALT (two of these were H. pylori negative and the other three were positive), whereas two patients showed grade 3 gastric MALT (without H. pylori infection).
CONCLUSIONS: This study shows that HCV not only may colonize gastric MALT but also may permit the development of a grade of acquired MALT, which may represent the first step toward a MALT lymphoma. However, further studies are needed to demonstrate the antigenic role of HCV in the progression of acquired MALT into MALT lymphoma.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135039     DOI: 10.1111/j.1572-0241.2002.05848.x

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

Review 1.  Low-grade B-cell MALT lymphoma of the stomach: a clinical challenge.

Authors:  A Tursi
Journal:  Surg Endosc       Date:  2005-05-04       Impact factor: 4.584

2.  HCV non-structural protein 3 and HCV RNA genome in non-Hodgkin lymphoma and transition of the serum HCV RNA level: a retrospective analysis in one institution.

Authors:  Souichi Shiratori; Yutaka Tsutsumi; Takahito Kawamura; Kazuhiro Kudo; Norihiko Shimoyama; Nobuo Masauzi; Junji Tanaka; Masahiro Asaka; Masahiro Imamura
Journal:  Int J Hematol       Date:  2008-03-06       Impact factor: 2.490

3.  Immunohistochemical detection of hepatitis C virus (genotype 4) in B-cell NHL in an Egyptian population: correlation with serum HCV-RNA.

Authors:  Iman Gouda; Ola Nada; Sameera Ezzat; Mai Eldaly; Christopher Loffredo; Clive Taylor; Mohamed Abdel-Hamid
Journal:  Appl Immunohistochem Mol Morphol       Date:  2010-01

Review 4.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

5.  Immune activation in HIV/HCV-infected patients is associated with low-level expression of liver expressed antimicrobial peptide-2 (LEAP-2).

Authors:  Mohamed Tarek M Shata; Enass A Abdel-Hameed; Helal F Hetta; Kenneth E Sherman
Journal:  J Clin Pathol       Date:  2013-08-12       Impact factor: 3.411

6.  The impact of hepatitis viruses on chronic lymphoproliferative disorders--preliminary results.

Authors:  Ana-Maria Vladareanu; Cristina Ciufu; Ana-Maria Neagu; Minodora Onisai; Horia Bumbea; Ana-Maria Vintilescu; Camelia Dobrea; Victoria Arama; Raluca Mihailescu; Sorin Arama
Journal:  J Med Life       Date:  2010 Jul-Sep

7.  HCV replication in gastrointestinal mucosa: Potential extra-hepatic viral reservoir and possible role in HCV infection recurrence after liver transplantation.

Authors:  Giovanna Russelli; Paola Pizzillo; Gioacchin Iannolo; Floriana Barbera; Fabio Tuzzolino; Rosa Liotta; Mario Traina; Giovanni Vizzini; Bruno Gridelli; Ester Badami; Pier Giulio Conaldi
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

8.  The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts.

Authors:  Chun-Wei Chen; Jur-Shan Cheng; Tai-Di Chen; Puo-Hsien Le; Hsin-Ping Ku; Ming-Ling Chang
Journal:  Therap Adv Gastroenterol       Date:  2019-06-17       Impact factor: 4.409

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.